Adenocarcinoma, Sebaceous
"Adenocarcinoma, Sebaceous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. (From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4)
Descriptor ID |
D018266
|
MeSH Number(s) |
C04.557.470.200.025.105 C04.557.470.550.105
|
Concept/Terms |
Adenocarcinoma, Sebaceous- Adenocarcinoma, Sebaceous
- Adenocarcinomas, Sebaceous
- Sebaceous Adenocarcinoma
- Sebaceous Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Sebaceous".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Sebaceous".
This graph shows the total number of publications written about "Adenocarcinoma, Sebaceous" by people in this website by year, and whether "Adenocarcinoma, Sebaceous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 2 | 0 | 2 |
2004 | 2 | 0 | 2 |
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 1 | 2 | 3 |
2015 | 3 | 0 | 3 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 5 | 0 | 5 |
2020 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma, Sebaceous" by people in Profiles.
-
HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases. Int J Gynecol Pathol. 2023 Jul 01; 42(4):338-346.
-
Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India. Acta Ophthalmol. 2023 Feb; 101(1):49-56.
-
Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis. Mod Pathol. 2020 07; 33(7):1256-1263.
-
Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019 12; 20(12):e699-e714.
-
Predictors of Local Recurrence for Eyelid Sebaceous Carcinoma: Questionable Value of Routine Conjunctival Map Biopsies for Detection of Pagetoid Spread. Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct; 35(5):419-425.
-
The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region. Eye (Lond). 2019 09; 33(9):1433-1442.
-
Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma. Br J Ophthalmol. 2020 06; 104(6):879-884.
-
Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019 Jun; 80(6):1608-1617.e1.
-
Squared-Off Nuclei and "Appliqu?" Pattern as a Histopathological Clue to Periocular Sebaceous Carcinoma: A Clinicopathological Study of 50 Neoplasms From 46 Patients. Am J Dermatopathol. 2017 Apr; 39(4):275-278.
-
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol. 2016 09; 240(1):84-95.